Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal bupivacaine PENG + lateral femoral cutaneous nerve block for analgesia after total hip arthroplasty
ChiCTR2400080696Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Guangxi Medical University
- Start
- Feb 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of liposomal bupivacaine, bupivacaine and ropivacaine in postoperative pain (3 arms), sponsored by The First Affiliated Hospital of Guangxi Medical University. Primary endpoints: Visual Analog Scale (VAS) scores and Quality of recovery-15 scale (QoR-15). Started Feb 2024; status: recruiting.
02
Drugs
liposomal bupivacainebupivacaineropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2400080696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400080696.